Citi Starts Ascendis Pharma (ASND) at Buy
Tweet
Share
E-mailGet Alerts ASND Hot Sheet
Price: $246.23 -3.61%
Rating Summary:
21 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
21 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
Citi analyst David Lebowitz initiates coverage on Ascendis Pharma (NASDAQ: ASND) with a Buy rating and a price target of $187.00.
For an analyst ratings summary and ratings history on Ascendis Pharma click here. For more ratings news on Ascendis Pharma click here.
Shares of Ascendis Pharma closed at $108.52 yesterday.
You May Also Be Interested In
- Ascendis Pharma (ASND) PT Raised to $333 at Jefferies
- Canaccord Starts Galiano Gold (GAU:CN) at Buy
- Alliance Global Partners Starts Momentus (MNTS) at Buy
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
